Showing results (341-350 of 486) with videos related to
Sort By:
Pageof 49
Cancer Research|October 16, 2003
Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanomaBoaz Nachmias, Yaqoub Ashhab, Vered Bucholtz, et al.Bioinformatics (Oxford, England)|January 22, 2020
Differential network analysis of multiple human tissue interactomes highlights tissue-selective processes and genetic disorder genesOmer Basha, Chanan M Argov, Raviv Artzy, et al.The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Dupilumab for cancer-associated refractory pruritusAviv Talmon, Shlomo Elias, Limor Rubin, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2013
Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cellsGalit Eisenberg, Ronny Uzana, Aviad Pato, et al.Clinical and Experimental Immunology|July 28, 2015
Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cellsA Pato, G Eisenberg, A Machlenkin, et al.Cancer Research|March 15, 2008
Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLsArthur Machlenkin, Ronny Uzana, Shoshana Frankenburg, et al.The Journal of Experimental Medicine|January 14, 2009
Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLsFernando Cruz-Guilloty, Matthew E Pipkin, Ivana M Djuretic, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
Trogocytosis is a gateway to characterize functional diversity in melanoma-specific CD8+ T cell clonesRonny Uzana, Galit Eisenberg, Yael Sagi, et al.International Journal of Dermatology|January 31, 2016
Widespread morbilliform rash due to sorafenib or vemurafenib treatment for advanced cancer; experience of a tertiary dermato-oncology clinicAyelet Ollech, Salomon M Stemmer, Sharon Merims, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?Livnat Brill, Lotem Goldberg, Arnon Karni, et al.Pageof 49